SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-052213
Filing Date
2020-11-09
Accepted
2020-11-09 08:00:34
Documents
3
Period of Report
2020-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K - Q-3 2020 EARNINGS alna-8k_20201109.htm 8-K 36826
2 EX-99.1 alna-ex991_6.htm EX-99.1 68868
3 GRAPHIC g02iyio4zbj3000001.jpg GRAPHIC 3522
  Complete submission text file 0001564590-20-052213.txt   111869
Mailing Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462
Business Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462 617-467-4577
Allena Pharmaceuticals, Inc. (Filer) CIK: 0001624658 (see all company filings)

IRS No.: 452729920 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38268 | Film No.: 201296166
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences